We serve the needs of pets and their people
To build advanced drugs for pets, Kedi Bioscience applies unique animal health insights to a blueprint of human-validated biologic targets.
Our platform technology has already yielded potent and developable drug candidates. We are currently advancing a pipeline of wholly owned assets addressing a range of prevalent feline diseases.
Oncology
Lead programs
Metabolism
Early pre-clinical
Inflammation
Early pre-clinical
We are looking for innovative partners to complement our drug development programs.
We are flexible, reasonable business partners with a commitment to animal welfare.
Get in touch to learn more about our pipeline assets.